DEXTROSE MONOHYDRATE - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2015-03-24
- Label type
- Indexing - product concept
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 00:14:57
Label at a glance#
ProductDEXTROSE MONOHYDRATE
Active ingredientDEXTROSE MONOHYDRATE, SOYBEAN OIL, SODIUM ACETATE, POTASSIUM CHLORIDE, SODIUM GLYCEROPHOSPHATE ANHYDROUS, MAGNESIUM SULFATE HEPTAHYDRATE, CALCIUM CHLORIDE, LYSINE HYDROCHLORIDE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID, TYROSINE
Products#
Every source-derived product name is available through these pages.
- DEXTROSE MONOHYDRATE
- ANHYDROUS DEXTROSE
- SOYBEAN OIL
- SODIUM ACETATE
- ACETATE ION
- SODIUM CATION
- POTASSIUM CHLORIDE
- POTASSIUM CATION
- CHLORIDE ION
- SODIUM GLYCEROPHOSPHATE ANHYDROUS
- PHOSPHATE ION
- MAGNESIUM SULFATE HEPTAHYDRATE
- MAGNESIUM CATION
- CALCIUM CHLORIDE
- CALCIUM CATION
- LYSINE HYDROCHLORIDE
- LYSINE
- PHENYLALANINE
- LEUCINE
- VALINE
- THREONINE
- METHIONINE
- ISOLEUCINE
- TRYPTOPHAN
- ALANINE
- ARGININE
- GLYCINE
- PROLINE
- HISTIDINE
- GLUTAMIC ACID
- SERINE
- ASPARTIC ACID
- TYROSINE
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DEXTROSE MONOHYDRATE | LX22YL083G | ACTIB |
| SOYBEAN OIL | 241ATL177A | ACTIB |
| SODIUM ACETATE | 4550K0SC9B | ACTIB |
| POTASSIUM CHLORIDE | 660YQ98I10 | ACTIB |
| SODIUM GLYCEROPHOSPHATE ANHYDROUS | YP1H63LJ2K | ACTIB |
| MAGNESIUM SULFATE HEPTAHYDRATE | SK47B8698T | ACTIB |
| CALCIUM CHLORIDE | M4I0D6VV5M | ACTIB |
| LYSINE HYDROCHLORIDE | JNJ23Q2COM | ACTIM |
| PHENYLALANINE | 47E5O17Y3R | ACTIB |
| LEUCINE | GMW67QNF9C | ACTIB |
| VALINE | HG18B9YRS7 | ACTIB |
| THREONINE | 2ZD004190S | ACTIB |
| METHIONINE | AE28F7PNPL | ACTIB |
| ISOLEUCINE | 04Y7590D77 | ACTIB |
| TRYPTOPHAN | 8DUH1N11BX | ACTIB |
| ALANINE | OF5P57N2ZX | ACTIB |
| ARGININE | 94ZLA3W45F | ACTIB |
| GLYCINE | TE7660XO1C | ACTIB |
| PROLINE | 9DLQ4CIU6V | ACTIB |
| HISTIDINE | 4QD397987E | ACTIB |
| GLUTAMIC ACID | 3KX376GY7L | ACTIB |
| SERINE | 452VLY9402 | ACTIB |
| ASPARTIC ACID | 30KYC7MIAI | ACTIB |
| TYROSINE | 42HK56048U | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 5dceb1b4-e97a-a4fd-e063-6394a90a0392 | 2026-10-14 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | REMEDYREPACK INC. | e2638b45-1141-4391-971d-c0dea825e41c | 2026-09-11 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 8cf6943f-16e8-4521-863c-09bb0b55e2a9 | 2026-09-09 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | REMEDYREPACK INC. | b8b77421-d687-45aa-82f6-d49bce644c10 | 2026-08-31 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 4ed365da-4e62-4329-c1b9-c197ab4fb6e1 | 2026-07-13 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 672264e3-9709-4bba-2a9d-12bf70c7396a | 2026-06-24 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 3bb406a9-f5cb-403a-b1bb-5c4facbea3d5 | 2026-06-11 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 10e98cb0-31a5-4ad1-3eaa-aa4af387a42d | 2026-06-02 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 40fd1ac4-39bb-45fb-ba99-4fb65481f231 | 2026-04-09 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | 8e7046f8-841e-465a-af69-af9fb3d6799d | 2026-03-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | 3b8f2692-4371-4f1a-95af-b41842131fdd | 2026-03-13 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | BECTON DICKINSON AND COMPANY | 32132016-1870-481b-9816-e11beb03ca0b | 2026-01-08 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | bd250a46-d229-4e80-b5a1-b34169ccecc4 | 2025-12-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical, Inc. | 8b25b7e0-703e-4b43-a4eb-52863511602d | 2025-11-02 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical, Inc. | cb578dba-094c-4787-951d-763d12fd06e1 | 2025-11-01 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical Inc. | cdf35d11-fbc8-4f8e-85a8-33220312c0b4 | 2025-10-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3eff8bcd-6a33-428f-e063-6394a90afa68 | 2025-09-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Company | bfc4224a-2fc9-4137-b4c6-9d2d6d948413 | 2025-07-30 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3842a9c0-8b15-1c94-e063-6394a90ae120 | 2025-07-18 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 36e9478c-5df0-4b47-b97d-de3626d7cb29 | 2025-06-30 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.